mRECIST Response Evaluation.

Note. Data in parentheses are percentages. The number of adverse events are defined considering all possible adverse events for both TAELE and cTACE groups. Adverse events (AE) belonging to CTCAE version 4.0 Grade 5 were not considered, as no casualty was registered in our series.TAELE = transarterial ethanol-lipiodol embolization. cTACE = conventional transarterial chemoembolization. CR = Complete Response. PR = Partial Response. SD = Stable Disease. PD = Progressive Disease.* Indicates the rate of adverse events occurred in the subgroup of males with CR, PR, SD or PD after TAELE or cTACE, respectively** Indicates the rate of adverse events occurred in the subgroup of females with CR, PR, SD or PD after TAELE or cTACE, respectivelymRECIST Response Evaluation.